ANTIDOTE TREATMENT
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract number SPE2DP25F133J, issued on July 22, 2026, for the provision of ANTIDOTE TREATMENT identified by NSN 6505015984306. This award is delivered under the parent contract SPE2DX15D9383, and while the total contract price is specified in the award documentation, it is not enumerated here. The award is issued through a federal procurement channel with no set-aside designation, and performance is expected to support Department of Defense requirements. The awardee, identified by CAGE code 1UNB0, is obligated to fulfill the delivery order for the specified medical countermeasure, with all contractual obligations governed by the terms outlined in the associated award record accessible through the DIBBS portal.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
